ISSN: 2278-0238

Revista internacional de investigación y desarrollo en farmacia y ciencias biológicas

Acceso abierto

Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.

Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores

Abstracto

INTEGRATION OF PROJECT-PRODUCT LIFECYCLE IN PHARMACEUTICAL INDUSTRY

Divya Chauhan, Nusrat Khan

One meaningful and holistic approach to today’s current challenges within the pharmaceutical industry is to focus on Product Lifecycle Management (PLM). PLM has provided many pharmaceutical organizations with the ability to get products to market quicker, ensure greater regulatory compliance and efficiencies while reducing development costs. A product life cycle is a conceptual map of - where a product's sales are and where they may be headed. However, it has no comment on what to do with the product. If a company believes its product is entering the decline phase, it will probably create a plan to either rejuvenate the product or cease production, but that is not inherent in the product life cycle. Thus, comes the concept of project life cycle (PLC), which is all about action. A project life cycle maps out the steps needed to complete a project with specific targeted results. Although these two lifecycles are talked about separately but if integrated can be of greater use to an organization